n/a
Abstract Title:

Efficacy of Plantago major seed in management of ulcerative colitis symptoms: A randomized, placebo controlled, clinical trial.

Abstract Source:

Complement Ther Clin Pract. 2021 Aug ;44:101444. Epub 2021 Jul 10. PMID: 34265576

Abstract Author(s):

Atiyeh Baghizadeh, Ali Davati, Ali Jafari Heidarloo, Fatemeh Emadi, Jale Aliasl

Article Affiliation:

Atiyeh Baghizadeh

Abstract:

OBJECTIVE: Evaluation of the effect of Plantago major (P. major) seed on ulcerative colitis (UC) symptoms.

METHODS: In this randomized double-blind clinical trial, 61 subjects received 3600 mg/day roasted P. major seed in intervention group (n = 31) and roasted wheat flour in control group (n = 30), for 8 weeks, as a complementary to standard medications. Variables were assessed using the Lichtiger Colitis Activity Index (LCAI) at baseline, week 4, and week 8.

RESULTS: 51 patients completed the trial (n = 28 in Plantago and n = 23 in placebo groups). Abdominal tenderness (p = 0.011), gastroesophageal reflux and gastric pain (p = 0.049 for both), were significantly less severe in P. major group. Visible blood in stool (p = 0.001), distension (p = 0.001), and anal pain (p = 0.051), decreased significantly in P. major group, although no significant difference was observed between the two groups: (p = 0.224), (p = 0.283), and (p = 0.455) respectively.

CONCLUSION: P. major seems to be effective in complementary management of UC.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.